Urol. praxi. 2022;23(2):58-65 | DOI: 10.36290/uro.2022.005

Urological disease in diabetic patient

MUDr. Miroslava Ryšánková1, MUDr. Marie Hurtová1, 2
1 Urologie Náchod, s. r. o., Náchod
2 Urologická klinika FN Hradec Králové

Patients with diabetes mellitus in the urology clinic are not exceptional. They are being examined for signs of common urological diseases as well as patients without diabetes. But also with complications in the urinary tract or genitals that are specific to the diabetic patient. These complications last for an unknown period of time, often oligosymptomatically. They are often life-threatening for patients. The actual treatment of these diseases consists not only in stabilizing the urological problem, but also in setting up and adjusting the treatment of diabetes. It can be said that diabetes increases the risk of urological problems and, conversely, urological problems (especially inflammation) can lead to decompensation of the patient's diabetes.

Keywords: diabetes mellitus, diabetic nephropathy, diabetic cystopathy, Fournier gangrene, emphysematous pyelonephritis, renal papillary necrosis.

Received: January 11, 2022; Revised: February 7, 2022; Accepted: February 9, 2022; Prepublished online: February 9, 2022; Published: June 1, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ryšánková M, Hurtová M. Urological disease in diabetic patient. Urol. praxi. 2022;23(2):58-65. doi: 10.36290/uro.2022.005.
Download citation

References

  1. Češka R, et al. Interna. 3. vydání, Praha: Triton, 2020;970 s.
  2. Pelikánová T, Bartoš V. Praktická diabetologie. 6 ed. Praha: Maxdorf. 2018;815 s.
  3. Pelikánová T, Viklický O, Rychlík I, et al. Doporučené postupy při diabetickém onemocnění ledvin 2021, Česká diabetologická společnost ČLS JEP, Česká nefrologická společnost a Česká společnost klinické biochemie ČLS JEP.
  4. Zima T, Racek J, Ryšavá R, et al. Doporučení k diagnostice chronického onemocnění ledvin (odhad glomerulární filtrace a vyšetřování proteinurie). Klin. Biochem. Metab. 2021; 29(2):94-103.
  5. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney inter. Suppl. 2013(3):1-150.
  6. National Kidney Foundation: KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Am J Kidney, DiS. 2012;60(5):850-886. Go to original source... Go to PubMed...
  7. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2020;98(4S):1-115. Go to original source... Go to PubMed...
  8. Lieske JC. Diabetes mellitus and the risk of urinary tract stones: a population­‑based casecontrol study. Am J Kidney, DiS. 2006;48:897-904. Go to original source... Go to PubMed...
  9. Lacigová S, Rušavý Z, Jirkovská A, et al. Doporučený postup diagnostiky a léčby diabetické neuropatie (2016), Doporučení české diabetické společnosti ČLS JEP, datum revize 23. 2. 2016, dmev; 2016,19(2):57-63.
  10. Yuan, Z, Tang Z, He Ch, et al. Diabetic cystopathy: a review. J Diabetes. 2015;7(4):442-447. Go to original source... Go to PubMed...
  11. Daneshgari F, Liu G, Imrey PB. Time dependent changes in diabetic cystopathy in rats include compensated and decompensated bladder function. J Urol. 2006;176:380-386. Go to original source... Go to PubMed...
  12. Ryšánková M. Dysfunkce dolních cest močových u diabetického pacienta. Urol. praxi. 2022;23(1):193-197. Go to original source...
  13. MINIRIN, Souhrn údajů o přípravku, sp. zn. Sukl s 185737/2018.
  14. Park J, Cho SY, Lee YJ, et al. Poor glycemic control of diabetes mellitus is associated with higher risk of prostate cancer detection in a biopsy population. PLoS One. 2014;9:e104789. Go to original source... Go to PubMed...
  15. Cai H, Xu Z, Xu T, et al. Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta­‑analysis of 11 cohort studies. Diabetes Metab Res Rev. 2015;31:336-343. Go to original source... Go to PubMed...
  16. Park SM, Lim MK, Shin SA, Yun YH. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol. 2006;24:5017-5024. Go to original source... Go to PubMed...
  17. Evans JM, Donnelly LA, Emslie­‑Smith AM, et al. Metformin and reduced risk of cancer in diabetic patients. BMJ. 2005;330:1304-1305. Go to original source... Go to PubMed...
  18. Stone HH, Martin JD, Jr. Synergistic necrotizing cellulitis. Ann Surg. 1972;175(5):702-711. Go to original source... Go to PubMed...
  19. Fournier JA. Gangrène­‑foudroyante de la verge. Semin Med. 1883;3:345.
  20. Broďák M, Romžová M, Košina J. Urologické výkony u diabetika. Vnitr Lek. 2008;54(5):457-463. Go to PubMed...
  21. Tang LM, Su YJ, Lai YC. The evaluation of microbiology and prognosis of fournier's gangrene in past five years. Springerplus. 2015;4:14. Go to original source... Go to PubMed...
  22. Venmans LM, Sloof M, Hak E, et al. Prediction of complicated urinary tract infections with type 2 diabetes: a questionnaire study in primary care. Eur J Epidemiol, 2007;22(1):49-54. Go to original source... Go to PubMed...
  23. Hrnčiříková A, Vachek J. Nebezpečné léky u nemocných s renálním poškozením - kdy a jak redukovat dávky. Med. praxi. 2016;13(4):176-179. Go to original source...
  24. Macek P. Komplikované infekce močových cest. Urol. praxi. 2010;11(6):302-307.
  25. Kladenský J. Infekce močových cest a diabetes mellitus. Urol. praxi. 2013;14(2):56-58.
  26. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell­‑Walsh Urology. 2007:271-273.
  27. Kapoor R, Muruganandham M, Gulia, AK, et al. Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis. BJU Int. 2010;105(7):986-989. Go to original source... Go to PubMed...
  28. Isidro ML. Sexual dysfunction in men with type 2 diabetes. Postgrad Med J. 2012;88(1037):152-159. Go to original source... Go to PubMed...
  29. Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L. Low levels of sex hormo­‑ne­‑binding globulin and testosterone predict the development of non­‑insulin­‑dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996;143:889-897. Go to original source... Go to PubMed...
  30. Pederson DF, Latini DM, Lubeck DP, et al. Do im­‑potent men with diabetes have more severe erectile dysfunction and worse quality of life than general population of impotent patients? Diabetes Care. 2003;26(4):1093-1099. Go to original source... Go to PubMed...
  31. Fonseca V, Seftel A, Denne J, Fredlund P. Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials. Diabetologia. 2004;47:1914-1923. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.